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EDITORIAL REVIEW
Escape from the sodium-retaining effects of
mineralocorticoids
The prolonged administration of pharmacologic
doses of mineralocorticoids to normal subjects re-
suits in hypokalemia, metabolic alkalosis, poly-
dipsia, polyuria, and transient sodium retention. Al-
though this review will focus on sodium metabo-
lism, increased water turnover was, in retrospect,
the first part of this constellation to be recognized.
Ragan et al [1], in 1940, demonstrated that the
chronic injection of deoxycorticosterone acetate
(DOCA) produced a syndrome of polydipsia and
polyuria in normal animals. These authors state that
their results could have been anticipated from the
earlier work of Tee! [2], Wermer [3], and also Sil-
vette and Britton [4]. Most importantly, Ragan et al
[1] demonstrated that there was no striking accumu-
lation of extracellular fluid or congestive heart fail-
ure when DOCA was administered to normal dogs;
that is, sodium retention was only transient, where-
as the hypokalemia was persistent, finally leading to
paralysis and death of the animal. Clinton and
Thorn, in 1943, extended these observations by
demonstrating that the chronic administration of
DOCA increased plasma volume of normal subjects
by 6% [5]. In 1950, Daughaday and MacBryde eval-
uated the effects of DOCA administration with both
deprivation and abundance of sodium in the diet [6].
Urine sodium excretion remained negligible during
DOCA treatment when the diet contained 3 mEq of
sodium per day. DOCA was administered again in
the presence of 203 mEq of sodium per day in the
diet. Following an initial period of sodium reten-
tion, sodium balance was restored, a finding similar
to that reported for the chronic administration of
cortisone and ACTH [7]. Although renal sodium ex-
cretion was high when sodium balance was re-
stored, the concentration of sodium in sweat was
low, indicating a continuing effect of the hormone.
Relman and Schwartz, who also studied the effects
of DOCA during variations of sodium intake, con-
cluded that the escape from the sodium-retaining ef-
fect of DOCA was the result of regulatory mecha-
nisms which override the hormonal effect on the
renal tubule [8]. The term escape" was introduced
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into the literature in this context. Because the term
has been widely used and provides a convenient de-
scription of the phenomenon, we will use the term
escape as an abbreviation in this review.
In 1958, August, Nelson, and Thorn extended
these observations with DOCA to the evaluation of
the response of normal subjects to aldosterone. Fol-
lowing an initial period of weight gain and sodium
retention, the weight gain ceased and sodium excre-
tion returned to control levels, despite continued
administration of the hormone [9] (Fig. 1). Again,
there was a more rapid return to sodium balance
with greater sodium intake, leading to the con-
clusion that escape was dependent on either extra-
cellular fluid volume or sodium retention rather
than the duration of treatment. An inactivation of
aldosterone by enhanced metabolism was consid-
ered unlikely in view of the continued effects on uri-
nary potassium excretion and on salivary and sweat
sodium concentrations [6]. Based on the work of
Bartter et al, volume was considered more impor-
tant than sodium because a natriuresis could be in-
duced by expansion of the extracellular fluid vol-
ume by administration of pitressin and water de-
spite sodium restriction [10]. Although this
conclusion may be correct, it is important to recog-
nize that aldosterone secretion, as determined by
urinary excretion, was decreased during vasopres-
sin administration.
Nephron sites of altered sodium reabsorption
The nephron sites of enhanced sodium reabsorp-
tion subsequent to mineralocorticoid action and
those responsible for escape may not be the same.
We will review the nephron sites of mineral-
ocorticoid action first. Although it is certain that
mineralocorticoids enhance sodium reabsorption in
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Fig. 1. Effect ofaldosterone administration to a normal subject
white 28-yr-old male. (Reprinted with permission of J Clin Invest
[9])
the cortical collecting tubule [11], a direct effect on
other tubule segments remains controversial. Al-
though aldosterone binding has been localized to
the proximal tubule, distal tubule, and collecting
duct [12], it is difficult to interpret the significance of
such binding with the demonstration that specific al-
dosterone binding may be dissociated from its mm-
eralocorticoid activity [131.
The evidence for a proximal site of action for
mineralocorticoids has been critically reviewed by
Ludens and Fanestil [141. Although an effect on
proximal sodium reabsorption cannot be ruled out
entirely, the review suggests that the proximal tu-
bule does not play a significant role in the renal re-
sponse to mineralocorticoids.
Most of the studies implicating the loop of Henle
as a site of mineralocorticoid-stimulated sodium
reabsorption have been based on free-water and os-
molar clearances, which are subject to alternative
interpretations in light of the considerable diluting
ability of the collecting duct [15]. Heirholzer et a!
[161 found an increased tubule fluid to plasma so-
dium (II(TF/PINa) concentration ratio in the early dis-
tal tubule of adrenalectomized rats that was de-
creased to control levels with aldosterone. Al-
though these data are suggestive of a mineralo-
corticoid effect on the loop of Henle, because
(TF/P)1 was not measured, the effect on sodi-
um reabsorption is uncertain. In microperfusion
studies, Murayama et al [171 observed no effect of
aldosterone on sodium reabsorption in the loop of
Henle of adrenalectomized rats. Companion free-
flow micropuncture studies indicated, however,
that aldosterone and cortisol decreased the (TF/P)Na
concentration ratio in the distal tubule. Thus, the
evidence to date does not conclusively indicate that
the loop of Henle is an important site of mineral-
ocorticoid action. As far as we know, this problem
has not been addressed with the isolated perfused
tubule preparation.
The distal tubule has been traditionally consid-
ered to be the major site of mineralocorticoid ac-
tion. Stop-flow, free-flow micropuncture, and mi-
croperfusion studies [16-201 have suggested that al-
dosterone enhances sodium reabsorption in the
distal tubule. Recent studies by Woodhall and Tish-
er [211 have shown, however, that as much as 45%
of the rat distal tubule (defined as that portion of the
nephron from the macula densa to the first junction
with another tubule) has the same histologic fea-
tures and function as the cortical collecting tubule.
Thus, these early studies of the "distal" tubule may
have reflected altered transport by the collecting tu-
bule. In addition, Gross and Kokko [22] found no
effect of aldosterone or spironolactone on the trans-
tubule potential difference in isolated distal tubules.
Further, in studies on rats fed either a normal or
low-sodium diet, no change in fractional sodium
reabsorption [231 or transtubule potential difference
[24] was detected along the distal tubule. In sum-
mary, recent evidence refutes the classic site of ac-
tion because mineralocorticoids do not affect distal
tubule sodium transport.
Mineralocorticoids are generally accepted to
stimulate sodium reabsorption in the cortical col-
lecting tubule. Wade et al [25] observed a marked
increase in basal plasma membrane infolding of
principal cells in cortical collecting tubules from
rabbits chronically treated with DOCA. Schwartz
and Burg demonstrated that isolated cortical col-
lecting tubules from rabbits fed a low-sodium and
high-potassium diet (a condition in which plasma al-
dosterone concentrations would be expected to be
elevated) developed a transepithelial potential dif-
ference that was more negative in the lumen than in
those tubules from a high-sodium and low-potas-
sium group [26]. Additional studies on isolated rab-
bit cortical collecting tubules treated with mineral-
ocorticoids both in vivo and in vitro have shown
clear enhancement of sodium flux [11, 261 and trans-
epithelial voltage [11, 22]. Thus, the cortical collect-
ing tubule emerges as an important site of mineralo-
corticoid action and, probably, the principal neph-
ron site of action.
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Studies on the papillary collecting duct have been
less conclusive. Uhlich, Baldamus, and Ullrich
[27], using the split-drop method, concluded that al-
dosterone increased the papillary collecting duct
reabsorptive capacity while decreasing the per-
meability to sodium. In a more recent study, using
similar techniques, Ulirich and Papavassiliou have
concluded that sodium reabsorption by the papil-
lary collecting duct is regulated by mineral-
ocorticoids [281. Further, micropuncture studies re-
vealed greater sodium reabsorption along the papil-
lary collecting duct in rats on low-sodium diets
when compared to normal diets despite similar de-
liveries to this segment [291. Conversely, Sonnen-
berg [30], using microcatherization, found that ad-
renalectomy affects sodium reabsorption only in the
outer medulla. Finally, Stein et al found no effect of
aldosterone on sodium-22 reabsorption in the col-
lecting duct of volume expanded rats [311, or of ad-
renalectomy on sodium reabsorption by the papil-
lary collecting duct [32]. Further studies are neces-
sary to clarify the role of mineralocorticoids in the
regulation of sodium reabsorption by the papillary
collecting duct.
The nephron site(s) of inhibited sodium reabsorp-
tion in escape may be distinct from those of miner-
alocorticoid-stimulated sodium reabsorption be-
cause no diminution of the enhanced sodium reab-
sorption in the cortical collecting duct has been
found [11, 261. A proximal site of escape was sug-
gested by Schacht, Lowenstein, and Baldwin [33]
based on free-water clearance studies. The assump-
tion in those studies that fluid delivery to the dilut-
ing segment was a measure of proximal tubule fluid
handling is questionable, however, because the
medullary concentration gradient and, hence, water
abstraction from the descending limb may not re-
main constant [34]. Further evidence for a proximal
site of mineralocorticoid escape has been presented
by Wright et al [35]. In this study, dogs given
DOCA for 5 to 13 days were found to have lower
(TFIP)1 concentration ratios in the late proximal
convoluted tubule than did the controls. Sub-
sequent micropuncture studies by Knox et a! [36]
revealed no difference between (TFIP)1 concentra-
tion ratios in the proximal tubules of dogs treated
with DOCA and either low- or high-salt diets. Al-
though the reason for the conflicting results is un-
certain, the control dogs in the Wright study were
untreated, whereas in the latter study they were
DOCA-treated and on a low-salt diet. The latter
study provided additional indirect evidence that
DOCA escape is not due to a greater proximal so-
dium delivery in that subsequent volume expansion
increased sodium delivery from the proximal tubule
similarly in both groups, but resulted in a signifi-
cantly greater natriuresis in the escaped dogs [36].
Studies in man [37] and dogs [38] found that hyper-
calciuria, but not phosphaturia, occurs with escape,
suggesting a decrease in sodium reabsorption at a
distal, but not proximal, nephron site. Finally, Son-
nenberg [39] showed no difference in proximal fluid
transport between salt-loaded DOCA-treated and
salt-deprived rats. It appears, therefore, that an in-
creased delivery of sodium from the proximal tu-
bule of superficial nephrons is not responsible for
escape. Proximal tubules of deep nephrons might,
however, handle sodium differently; this possibility
will be discussed in a following section.
Little data is available concerning sodium reab-
sorption by the loop of Henle during escape.
Schnermann et al [40] microperfused the ioop of
Henle in DOCA-treated and control rats. Fluid and
chloride reabsorption did not differ between the two
groups at perfusion rates of 15 and 40 nllmin. In ad-
dition, Sonnenberg [39] observed no differences in
sodium reabsorption by the loop of Henle between
salt-deprived and salt-loaded DOCA-escaped rats
as calculated by comparison of differences between
the late proximal and early distal tubule. Haas et al
[41] noted, however, greater sodium delivery in the
superficial distal tubule in acutely volume-expanded
DOCA-escaped rats as compared with controls
(Fig. 2). The failure to detect changes in sodium
reabsorption in the loop of Henle in the former stud-
ies [39, 40] may have been due to the compromised
volume state of the animals [42]. Thus, superim-
posed volume expansion in the latter study [41] may
have unmasked the contribution of the loop of
Henle in escape. Consequently, although the neph-
ron site responsible for the increase in sodium deliv-
ery to the superficial distal tubule is in need of more
precise localization, based on the previous consid-
erations ruling out the proximal tubule, the loop of
Henle remains a prime candidate.
As previously mentioned, sodium transport by
the isolated cortical collecting tubule from the rab-
bit is stimulated markedly by mineralocorticoid pre-
treatment [11]. These same rabbits, however, had
escaped from the sodium-retaining effects of
DOCA. Because sodium transport was markedly
stimulated in the cortical collecting tubules, this ef-
fect was not decisive for the final regulation of so-
dium excretion. Rather, the increased reabsorption
in the cortical collecting duct may be overcome by
increased delivery of sodium to this segment.
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Fig. 2. Fractional deliven' of sodium (FDvd to the superficial distal tubule and to the base of the papilla.for volume-expanded control
rats (left) and for volume-expanded DOGA -treated rats (right) [42].
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Fig. 3. Fractional delivery of sodium to the base and tip of the
papillary collecting duct for volume-expanded control and t'ol-
urn c-expanded DOCA-trea ted rats [42].
Sodium reabsorption by the papillary collecting
duct is similar in DOCA-escaped and normal rats.
In the micropuncture studies by Haas, Berndt, and
Knox [41], sodium reabsorption by the papillary
collecting duct was not changed by DOCA treat-
ment (Fig. 3). On the other hand. Sonnenberg [431,
using microcatheterization, observed no net sodium
reabsorption along the papillary collecting duct in
either volume-expanded DOCA-treated rats or con-
trol rats. The reason for the failure to detect sodium
reabsorption in the papillary collecting duct with
the microcatheterization technique may be due to
blockade of the most proximal nephron segments
when the catheter is fully inserted. When it is with-
drawn, the obstruction may be progressively re-
leased. Hence, the (TF/P)1 ratios remain constant
as a function of the length of the collecting duct and
artifactually indicate the absence of reabsorption.
Based on the free-flow micropuncture studies [41],
we conclude that the papillary duct may not play an
important role in escape from the salt-retaining ef-
fects of mineralocorticoids.
The possibility of heterogeneous sodium handling
between superficial and deep nephrons during es-
cape was mentioned earlier in the review. In micro-
puncture studies, there was greater sodium delivery
to the late superficial distal tubule than to the base
of the papillary collecting duct in the DOCA-treated
group, whereas an apparent secretion of sodium oc-
curred in the controls [411. This apparent secretion
during volume expansion in control rats has been
interpreted as greater sodium delivery from deep
rather than superficial nephrons. The possibility re-
mains, however, that sodium reabsorption by deep
nephrons may be decreased in escape as well.
Finally, a word of caution in regard to inter-
pretation of micropuncture studies for the local-
ization of escape. Invasive procedures have the in-
herent limitation that the volume status of the ex-
perimental animal may be altered by the surgical
preparation. Customarily, fluids are infused to re-
place surgical losses; however, it is doubtful that
the presurgical volume status of the animals is pre-
cisely restored [421. In those studies in which addi-
tional volume expansion is superimposed, dif-
ferences between control and escaped animals may
be due to mechanisms other than those that underlie
escape.
The role of he;nodvnamic and phvsicalfactors
An increased GFR has been suggested to be re-
sponsible for the return to sodium balance during
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chronic DOCA administration. Biglieri and For-
sham observed a significant increase in GFR in sub-
jects with aldosterone-secreting tumors who were
in sodium balance that returned to normal values
following surgical removal of the tumors [44].
Schnerman observed a blunted glomerular-tubular
feedback response in DOCA-escaped, volume-ex-
panded rats, suggesting that in escape an inhibition
of feedback control of GFR may lead to increased
sodium excretion [391. Despite the evidence impli-
cating a role for GFR in escape, other studies mini-
mize the association. Significant reductions in GFR
by aortic or renal artery constriction following
acute volume expansion failed to block the natriu-
retic response to volume expansion [45, 461. In the
hypophysectomized dog, Davis et al were unable to
block escape despite a significant reduction in the
GFR [49]. Thus, escape may occur in the absence of
an increased GFR.
Observations conflict regarding the effects of
changes in hematocrit during chronic DOCA admin-
istration. August, Nelson, and Thorn observed a
progressive decrease in hematocrit in human sub-
jects receiving chronic mineralocorticoid treatment
[9]. The work of Dahlmann et al has suggested that
changes in hematocrit may affect directly changes
in renal vascular resistance; thus, a decrease in he-
matocrit as observed by August et al, by decreasing
renal vascular resistance, would favor enhanced
natriuresis [50]. Contrary to the above observa-
tions, Davis and Howell failed to note any signifi-
cant change in hematocrit in experimental animals
during the chronic administration of mineralo-
corticoids [51]. Thus, it is difficult to imply a cru-
cial role for hematocrit in escape. Similarly, chronic
administration of mineralocorticoids does not sig-
nificantly alter protein metabolism [52]. Thus,
serum protein concentration, including albumin
concentration, is not significantly changed as com-
pared to edematous states known to be associated
with significant hepatic derangement of protein me-
tabolism. Serum protein concentration and, there-
fore, plasma oncotic pressure most likely plays little
role in escape.
The positive relationship between arterial blood
pressure and sodium excretion may have important
relevance in escape. Chronic mineralocorticoid ad-
ministration and primary aldosteronism are both
characterized by diastolic hypertension [9, 44]. The
models characterized by failure to escape, such as
thoracic vena caval constriction, are associated
with significant reductions in arterial pressure [53].
Further, an enhanced natriuretic response to acute
volume expansion has been documented well in hy-
pertensive subjects [54]. Studies by Higgins, how-
ever, suggest that escape is independent of altera-
tions in arterial blood pressure because escape oc-
curred in the presence of significant reduction in
arterial blood pressure by the administration of gua-
nethidine and hydralazine [55]. An alternative ex-
planation is that the hydralazine administration may
have resulted in renal vasodilation, permitting an
enhanced transmission of pressure to the pen-
tubular capillaries, thus attenuating the effects of a
reduced systemic arterial pressure. The observa-
tion, in the same study, that dogs with caval con-
striction failed to escape from DOCA during eleva-
tions of arterial pressure, further supported the au-
thor's hypothesis that escape was independent of
arterial pressure. Again, an alternative inter-
pretation is that the ephedrine administered for its
pressor effects may have resulted in significant
vasoconstriction within the renal circulation, thus
preventing a natriuretic response to an increased
systemic arterial pressure. This latter interpretation
is supported by studies of sodium metabolism in
normal dogs and caval constricted dogs. Earley and
Friedler observed that the infusion of angiotensin or
norepinephrine in acutely volume-expanded dogs in
the presence of unilateral vasodilation resulted in a
sustained and significant increase in sodium excre-
tion in the vasodilated kidney, but sodium excretion
usually decreased in the control nonvasodilated kid-
ney [56]. A later study by the same investigators in
sodium-retaining, thoracic-caval-constricted dogs
showed a reversal of the sodium-retaining state by
maneuvers similar to those used in the earlier study
[57]. The authors concluded from these two studies
that the combination of elevated arterial pressure
and reduced renal vascular resistance results in de-
creased tubule reabsorption of sodium, probably
through intrarenal mechanisms. These observations
have been verified extensively and extended, in-
dicating a role for physical factors in the regulation
of sodium excretion [58—61]. Further studies are
needed to test the attractive hypothesis that an ele-
vated systemic arterial pressure in combination
with renal vasodilation is an important factor in es-
cape.
Measurements during acute volume expansion
clearly document a striking positive correlation be-
tween renal interstitial pressure and sodium excre-
tion [62]. This association has been further strength-
ened by observations that reductions in renal per-
fusion pressure by renal artery constriction prior to
volume expansion blocked both the increase in re-
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nal interstitial pressure as well as the natriuretic re-
sponse to volume expansion [63]. Perhaps, in es-
cape, an increase in renal interstitial pressure re-
sulting from increased renal perfusion pressure and!
or expansion of the extracellular volume results in
decreased sodium reabsorption either directly as a
physical factor or indirectly through a hurnoral fac-
tor. Conversely, the failure to escape, as in thoracic
caval constriction [64], biliary duct ligation [65],
and experimental heart failure [66], which may be
associated with a decreased renal perfusion pres-
sure and!or decreased effective extracellular vol-
ume, may be related to an unchanged or decreased
renal interstitial pressure. Thus, the kidney may
serve as an important volume!pressure receptor in-
fluencing intrarenal mechanisms mediating escape.
Renin-angiotensin syste,n
Another possible mechanism responsible for mm-
eralocorticoid escape is that angiotensin II (All)
might alter sodium excretion independent of its ef-
fect on aldosterone secretion. Recent studies, by
Hall et al [67, 68] demonstrated that, in dogs with
the renin-angiotensin system activated by sodium
depletion, blockade of All increased urinary so-
dium excretion fivefold without changes in circulat-
ing aldosterone concentration. Several laboratories
have demonstrated that acute infusion of All at
physiologic levels produced renal vasoconstriction
and caused a marked decrease in urinary sodium
excretion [69-711. Chronic infusion studies by Hall
et at [72] demonstrated only a transient decrease in
sodium excretion, but that sodium balance was
maintained subsequently at a higher arterial pres-
sure. These authors concluded that chronic All in-
fusion altered the normal relationship between arte-
rial pressure and urinary sodium excretion. Be-
cause no changes in glomerular filtration were
observed in the dogs chronically infused with All,
the authors speculated that the increased absorp-
tion of sodium might be secondary to altered phys-
ical forces in the peritubular capillaries consistent
with the observed decrease in renal plasma flow.
Angiotensin II, however, might have a direct effect
on the tubule epithelium to increase sodium reab-
sorption as suggested by others [73—75]. Recently, a
chronic intravenous infusion of physiologic
amounts of All was reported to impair the ability of
the kidney to excrete a saline load in the presence of
relatively low levels of plasma aldosterone [76]. Re-
gardless of the specific mechanism, it is clear that
All has a potent effect on sodium excretion inde-
pendent of changes in aldosterone secretion.
Perhaps the chronic administration of mineralo-
corticoids, and the subsequent expansion of the
extracellular fluid volume, leads to a suppression of
All concentrations, which contributes to escape.
Similarly, when All is stimulated, or fails to be sup-
pressed, then the kidney remains under the sodium-
retaining influences of All. In many of the condi-
tions where marked sodium retention occurs during
mineralocorticoid administration, there is evidence
for increased activity of the renin-angiotensin sys-
tem [49, 77, 78]. On the other hand, in those condi-
tions where mineralocorticoids are elevated without
chronic sodium retention (that is, escape), often the
renin-angiotensin system is suppressed. To deter-
mine if All, or the lack of it, might be responsible
for escape, Johnston et at [79] measured PRA dur-
ing the administration of DOCA in two groups of
dogs with aortic-caval fistulas. Dogs with a small
fistula demonstrated the normal escape, but dogs
with a larger fistula failed to escape from the so-
dium-retaining actions of the steroid and sub-
sequently developed the signs of congestive heart
failure. Despite marked differences between dogs
with a large or small fistula in regard to their renal
response to DOCA, both groups had comparably
suppressed PRA's, although there was greater vari-
ability in the dogs with a large fistula (Fig. 4). These
results strongly suggest that the circulating renin-
angiotensin system does not mediate the escape
phenomenon. Further studies are necessary to firm-
ly rule out a role for intrarenal All, including the
possibility of altered receptor activity.
Renal adrenergic system
An effective expansion of some fluid volume
compartment is widely held to be a central com-
ponent of escape. This thesis leads to the question
of how this volume expansion is perceived and the
formulation of the concept of fluid volume recep-
tors. Several studies have reported the importance
of sympathetic afferent fibers in initiating a volume
reflex mechanism in controlling sodium excretion
following acute volume expansion. Pearce and Son-
nenberg [80] demonstrated that spinal cord section
at CS completely abolished the natriuresis associat-
ed with the infusion of artificial blood. Studies by
Gilmore and Daggett [81] and Knox, Davis, and
Berliner [82] reported that dogs with denervated
hearts demonstrated a blunted natriuretic response
to volume expansion. Studies by McDonald et al
[83] also demonstrated an impaired natriuretic re-
sponse to volume expansion in dogs with spinal sec-










Fig. 4. A Mean plasma renin levels (±sEM)forfive dogs with a small arteriovenousfistula during the control period and after placement
of an arteriovenousfistula, for the first 5 days after DOCA administration (DOCA + sodium retention), and during DOCA escape." B
Dogs with a large arteriovenousfistula during the control periods and during the congestive syndrome produced by DOCA administra-
tion [80].
animals with sections at T6. These studies sug-
gested a requirement for normal innervation of the
thoracic viscera to observe the full effect of acute
volume expansion on sodium excretion. To ascer-
tain whether the spinal section at C6 blunted the
natriuresis of volume expansion by interruption of
afferent or efferent nerve fibers, studies were per-
formed in animals with dorsal-root section (C6 to
T6) to selectively interrupt afferent neural pathways
from the thorax. These animals demonstrated a nor-
mal response to volume expansion suggesting that
afferent fibers from the thorax are not important to
the natriuresis of volume expansion, Additional
studies by McDonald et a! [83] demonstrated a nor-
mal pattern of sodium retention, followed by escape
in dogs given DOCA both before and after C6 cord
section, suggesting that escape is independent of in-
put from the sympathetic nervous system (Fig. 5).
Finally, Kaloyanides et al [84, 85] used a cross-
circulation technique, involving an isolated dog kid-
ney, to demonstrate that the natriuretic response to
acute saline loading was abolished by decapitation,
but not by hypophysectomy. The authors con-
cluded that "the brain is either the source of natri-
uretic factor or that the brain plays a critical role in
activating the humoral natriuretic mechanism at
some other site in the body." It will be difficult to
determine if this interruption of the natriuretic re-
Refore cord section, days After cord section, days
Fig. 5. Effect on DOCA administration in two dogs before and
after spinal cord section at CO. (Reprinted with permission of
Am J Physiol [101])
sponse to saline loading by decapitation would also
prevent escape.
It now seems clear, based on morphologic evi-
dence for direct tubular innervation of the tubule
[86-88], and on clearance and micropuncture stud-
ies [89—101], that the renal nerves can affect directly
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ability of the renal nerves to alter sodium excretion,
the possibility must be considered that the sodium
retention produced by mineralocorticoid adminis-
tration leads to alterations in renal efferent nerve
traffic and thereby mediates escape. Evidence sup-
porting changes in the renal adrenergic system with
chronic administration of DOCA was reported by
Ljungqvist [1021, In this study, concentrations of
renal adrenergic transmitter, as measured by his-
tofluorescence, were decreased in rats treated with
a high-salt diet and DOCA.
Evidence against a role for the renal nerves in
mediating escape was provided by Davis et al in
studies where the kidney was transplanted to the
neck of adrenalectomized dogs [49]. Following the
administration of DOCA, the usual escape oc-
curred. The authors concluded that the mechanism
cannot be neurally mediated because all nerves to
the kidney were cut during transplantation. A simi-
lar conclusion was reached by Higgins [55], who re-
ported that dogs chronically treated with guanethi-
dine also demonstrate escape. Although the dogs in
the study by Davis et al [49] were adrenal-
ectomized, eliminating a primary source of circulat-
ing catecholamines, denervated organs, as well as
guanethidine-treated animals, can exhibit a hyper-
sensitivity to catecholamines; therefore, final judg-
ment concerning a role for neural influences in es-
cape await studies in which circulating catechol-
amines are also evaluated.
Although the available evidence suggests that es-
cape occurs in the absence of both afferent and ef-
ferent neural pathways, the failure of interruption of
this single regulatory mechanism may be obscured
by other compensatory mechanisms [1031.
Ka!/ikrein-kinin and prostaglandins
Kinins and prostaglandins have been considered
as mediators of escape because they are so closely
linked to sodium and water metabolism. Killikrein
and prostaglandin synthetase localization within
renal structures indicates that both enzyme systems
are associated with the late distal and cortical col-
lecting tubules. Application of stop-flow techniques
to this problem has resulted in detection of kalli-
krein secretion at the level of the distal convoluted
tubule as well as at more terminal segments [104].
Immunohistochemical confirmation demonstrated
the presence of kallikrein at the apex of distal tubu-
lar cells [105]. Whether or not the sodium-retaining
effects of mineralocorticoids in the cortical collect-
ing tubule are influenced by mineralocorticoid-stim-
ulated kallikrein excretion in the distal tubule re-
mains to be determined. Similarly, with immuno-
histochemical methods, prostaglandin synthetase
has been identified within the cortical collecting tu-
bules [106—1081. Thus, the strategic location of
these enzyme systems provides an anatomical basis
to suggest a potential interaction, not only with
each other, but also with mineralocorticoids.
Initial observations by Adetuyibi and Mills dem-
onstrated that urinary kallikrein excretion was in-
creased in subjects during the escape from the so-
dium-retaining effects of mineralocorticoids [1091.
At the same time, other investigators confirmed that
urinary kallikrein was elevated in DOCA-salt hy-
pertension [110, 111]. Further, urinary kallikrein
excretion was elevated in primary aldosteronism
and was reduced in adrenalectomized rats [111].
That renin was not a significant factor regulating
urinary kallikrein excretion was derived from the
observation that DOCA administration (low renin)
and low-sodium diet (high renin) were both associ-
ated with elevated kallikrein excretion [111]. Addi-
tional support for the relationship between mineral-
ocorticoids and urinary kallikrein was found when
kallikrein activity was demonstrated to be increased
by aldosterone and decreased by spironolactone in
suspensions of rat renal cortical cells, raising the
possibility that kallikrein could be an aldosterone-
induced protein [112]. More recently, when three
levels of dietary potassium were fed to normal and
hypertensive subjects for 5 to 10 days, renal kalli-
krein and aldosterone excretions varied directly
with potassium intake [1131. Thus, the data showed
a direct relationship between mineralocorticoids
and kallikrein excretion and support the proposition
by Geller et al that mineralocorticoids are a primary
factor stimulating urinary kallikrein excretion [111].
To evaluate the role of kallikrein in escape, the hy-
pothesis should be tested that urinary kallikrein ex-
cretion may be attenuated in models that do not es-
cape from the salt retaining effects of mineralo-
corticoids, that is, in heart failure.
Aprotinin, a kallikrein inhibitor, has been admin-
istered during continued mineralocorticoid treat-
ment in rats [114]. Mineralocorticoid administration
increased urinary kallikrein excretion, renal tissue
kallikrein, urinary prostaglandin E excretion, and
urine volume. These effects were significantly at-
tenuated when aprotinin was added. In addition, so-
dium excretion was decreased during the first day of
aprotinin treatment, but was increased by the fourth
day. The authors of this study concluded that mm-
eralocorticoids enhance urinary prostaglandin E ex-
cretion, an effect that appears consequent to activa-
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tion of the renal kallikrein-kinin system, and that
increased sodium excretion is the result of coopera-
tive action of the kallikrein-kinin and prostaglandin
system.
Two investigators have examined the actions of
exogenous prostaglandin on sodium transport by
isolated cortical and outer medullary collecting tu-
bules from rabbits pretreated with DOCA [115,
1161. In both of these studies, addition of prosta-
glandin E2 to the bathing medium, but not to the
perfusate, resulted in significant reductions of trans-
tubular potential difference as well as marked inhi-
bition of sodium reabsorption [115, 116]. Further,
prostaglandins E1 and F2, but not A2, exerted ef-
fects similar to those observed for prostaglandin E2
[116]. Although these results indicated an inhibitory
effect of prostaglandins on sodium transport, an ob-
servation consistent both with a natriuretic action
of these compounds and their participation in mm-
eralocorticoid escape, the in-vitro conditions may
not approximate the effects of endogenous prosta-
glandin production. First, pharmacologic concen-
trations of the various prostaglandins were applied
extracellularly [115, 116], and second, fetal calf
serum, which contains significant quantities of pros-
taglandins [1171, was added to the bath and dis-
section solutions in one study [1151. With these res-
ervations in mind, prostaglandins also have been
shown to inhibit sodium chloride transport in isolat-
ed ascending limbs of the loop of Henle from rabbits
[1181. This observation complements our sugges-
tion that altered transport in the ascending limb
might be involved in escape.
The contribution of renal prostaglandins to es-
cape has been examined in several studies. Escape
from the sodium-retaining effects of DOCA oc-
curred in dogs on a high-salt diet within the first day
without alteration in urinary prostaglandin excre-
tion [119]. By day 6 of treatment, hypokalemia, hy-
pernatremia, increased urinary prostaglandin E2
and F2,. excretion, increased polyuria, and sup-
pressed plasma renin activity had developed. When
potassium supplements were superimposed upon
DOCA treatment, the changes in urinary prosta-
glandin excretion, urine volume, and serum sodium
were all attenuated. Indomethacin administration
did not affect DOCA escape or its time course in
this or a previous study [120], suggesting that pros-
taglandins were not a contributing factor. In a sepa-
rate study, the affect of indomethacin (2 mg/kg/day)
on the increased water turnover, characteristic of
chronic DOCA treatment with a high-salt diet, was
evaluated in dogs [121]. Indomethacin had no effect
on the return to sodium balance, as above, but pre-
vented the increased water turnover. It was con-
cluded that prostaglandins may play a role in the
increased water turnover associated with escape
and that this may be related to the concurrent hy-
pokalemia. It is difficult to draw definitive con-
clusions in regard to the role of prostaglandins as
mediators of escape from the sodium-retaining ef-
fects of mineralocorticoids, because the doses of in-
domethacin used are relatively low and complete in-
hibition of prostaglandin synthetase cannot be as-
sured. The relatively low dose is necessary because
of the chronic nature of the experiments; attempts
to use larger doses result in fluid and electrolyte
effects in the gastrointestinal tract that invalidate
balance experiments. On the other hand, even with
this relatively low dose of indomethacin, significant
effects on water turnover were demonstrated.
In studies in humans who received either DOCA
alone for 10 days or DOCA plus indomethacin or
ibuprofen for a similar duration, DOCA administra-
tion increased urinary kallikrein excretion in the
presence or absence of the prostaglandin synthetase
inhibitor [122]. Further, inhibition of urinary prosta-
glandin excretion during DOCA administration ap-
peared to facilitate rather than to retard escape, al-
though total weight gain and sodium retention were
unaltered [122].
In summary, the relationship of the renal kalli-
krein-kinin and prostaglandin systems to salt and
water metabolism and to escape is only partially un-
derstood. Nevertheless, the initiation of escape pri-
or to increased prostaglandin excretion, the rever-
sal of this excretion with potassium supplements,
and the failure to block escape with inhibitors of
prostaglandin synthetase, all suggest that changes
in prostaglandin metabolism may be secondarily in-
duced by chronic mineralocorticoid administration,
but that prostaglandins do not mediate escape.
Natriuretic hormone
A circulating natriuretic factor has been postulat-
ed as a mediator of escape. De Wardener has re-
cently reviewed the evidence in support of a natri-
uretic hormone [123, 124]. For example, if animals
are expanded with a solution that is in equilibrium
with the test animal's blood, the blood of the vol-
ume-expanded animal can be used to perfuse a de-
nervated assay kidney at constant pressure [125].
The resulting natriuresis in the assay kidney was at-
tributed to a circulating natriuretic substance. Son-
nenberg, Veress, and Pearce have performed simi-
lar experiments except that a whole animal was
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used as the assay preparation [126]. Again, in-
creased sodium excretion was interpreted to in-
dicate that a change in the concentration of some
substances controls urinary sodium excretion.
Additional experiments suggest the presence of a
natriuretic factor rather than a decrease in an anti-
natriuretic factor in volume expansion. Pearce and
Veress [1271 evaluated the natriuretic effects of ex-
tracts from plasma obtained before and after vol-
ume expansion. The extracts from volume-ex-
panded animals were natriuretic in the assay ani-
mals. Buckalew and Lancaster evaluated a humoral
factor in plasma of dogs before and after administra-
tion of DOCA [128]. They demonstrated that escape
from the salt-retaining effects of DOCA correlated
with sodium transport inhibitory activity in plasma
as determined in a toad bladder assay.
Although the site of origin of natriuretic factors is
not definitive, the factor has been demonstrated in
animals in the absence of the adrenals [126, 129,
130], kidney, parathyroids, thyroids, and the pitui-
tary [129]. On the other hand, Kaloyanides et al did
not find a natriuresis in an isolated perfused kidney
when perfused with blood from a volume-expanded
decapitated dog [129]. These and other authors fa-
vor an origin in the brain [124, 131, 1321.
Despite the many studies where a natriuretic fac-
tor has been sought in urine, a clear consensus has
not been reached concerning molecular weight, du-
ration of action, or resistance to chemical treat-
ments [133—136]. Favre et al reported the presence
of an inhibitor of sodium transport that was isolated
from urine of dogs with normal renal function [137].
A Sephadex G-25 gel filtration fraction was tested in
toad bladder and rat bioassay systems. The fraction
obtained from escaped dogs inhibited short-circuit
current and induced a natriuresis in the two assay
systems, respectively. Deletion of either sodium or
mineralocorticoid prevented the response in the
toad bladder or both systems. Thus, the assay re-
suits correlated with the state of sodium retention
engendered by the mineralocorticoid administra-
tion. Because there may be many natriuretic factors
in urine, dramatically demonstrated in reinfusion
experiments, known factors must be ruled out be-
fore firm conclusions in regard to a new and unique
natriuretic hormone can be drawn.
In summary, despite a vigorous search for a natri-
uretic hormone, which might mediate escape, the
existence of such a natriuretic hormone remains in
question. Perhaps this question will linger until the
sites of origin, its effects, and its precise chemical
nature are known. The search for a natriuretic hor-
mone is not obligatory, and yet this cannot be ruled
out as one of several participating mechanisms.
Summary
In our opinion, it is unlikely that a single factor
mediates escape. Interruption of a single system, as
repeatedly demonstrated in this review, does not
prevent escape, probably due to activation of other
mechanisms. For this reason, the evidence does not
firmly rule out the participation of many of the indi-
vidual mechanisms discussed in this review. Most
likely, an interplay of several compensatory mecha-
nisms mediates escape from the salt-retaining effect
of mineralocorticoids. As stated by Smith [1031,
where multiple controls are super-imposed on a
function, such as sodium excretion, it is conceived
that normal regulatory mechanisms may be ob-
scured by compensatory reactions."
The mechanism for escape from the salt-retaining
effects of mineralocorticoids is not proven. In con-
sideration of all of the foregoing, our current view
of the mechanism for escape is as follows: Salt and
water retention leads to expansion of an effective
vascular volume, stimulation of volume receptors,
and subsequent decreases in renal adrenergic activi-
ty. This decreased renal adrenergic activity directly
decreases sodium transport as well as vasodilates
the kidney, allowing increased transmission of sys-
temic blood pressure to the renal vasculature.
These factors, perhaps modulated by intrarenal hor-
mones, increase sodium excretion and thereby me-
diate the escape from the salt-retaining effects of
mineralocorticoids.
FRANKLYN G. KNOX
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